Vertex: A Biotech Worth Considering (Possibly)

Investing in these companies early can yield spectacular returns, assuming they don’t encounter any…unforeseen difficulties (like, say, accidentally creating a self-replicating protein that consumes all organic matter – it’s happened in simulations, you know). The risk, naturally, is substantial. So, how does one navigate this minefield of potential breakthroughs and equally potential disasters? The answer, as is so often the case, is to look for a company that’s already managed to avoid the most obvious pitfalls. One that’s, shall we say, demonstrated a minimal level of competence.








